{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-26T12:25:36.524297+00:00",
  "news": [
    {
      "title": "Top Analyst Reports for NVIDIA, AT&T & Amgen - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTFB2MVNrY2NhVG9ONl9ocnNaRWpBZURvVk9GUkxLSm5NMUVGMUNnTzJDM0lXTk40bFk2S3lJV2tlb1pfSE5wdDBFNG01Tnhkd2l1UmdQU3M1T21RR0lOek5lYlBjdnRmcVQxR29WZGtuQWltc0I1TDh2RnNEMVdUc28?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTFB2MVNrY2NhVG9ONl9ocnNaRWpBZURvVk9GUkxLSm5NMUVGMUNnTzJDM0lXTk40bFk2S3lJV2tlb1pfSE5wdDBFNG01Tnhkd2l1UmdQU3M1T21RR0lOek5lYlBjdnRmcVQxR29WZGtuQWltc0I1TDh2RnNEMVdUc28?oc=5\" target=\"_blank\">Top Analyst Reports for NVIDIA, AT&amp;T & Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-25T21:44:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "How FDA Approval and New Guidelines for IMDELLTRA Could Shape Amgen (AMGN) Investor Expectations - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">How FDA Approval and New Guidelines for IMDELLTRA Could Shape Amgen (AMGN) Investor Expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-26T03:31:20+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen cholesterol drug cuts risk of first cardiac event by 25% - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5\" target=\"_blank\">Amgen cholesterol drug cuts risk of first cardiac event by 25%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-11-08T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5\" target=\"_blank\">Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump - The Wall Street Journal",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "The Wall Street Journal"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "The New York Times"
    },
    {
      "title": "Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5\" target=\"_blank\">Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-11-08T08:00:00+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Amgen at the Milken Future of Health Summit 2025 - Amgen",
      "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNNmowWU56TkZKTE5aRklDTEhfOWlJdmFNRGJ6MWM4SnBtN2Juc3BDS284bzV4SUtSZXdaS1NSVUhHRnFaU3ZMWHc2TGRXS3BSYkYwcjUxWmE1d20yQmx4TU5BYUxoTEhKcDB0cTRuOFZhblJYSVpBeFhmaXgyWjU4UDZ0WVdzN3RndlNUNjVaNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxNNmowWU56TkZKTE5aRklDTEhfOWlJdmFNRGJ6MWM4SnBtN2Juc3BDS284bzV4SUtSZXdaS1NSVUhHRnFaU3ZMWHc2TGRXS3BSYkYwcjUxWmE1d20yQmx4TU5BYUxoTEhKcDB0cTRuOFZhblJYSVpBeFhmaXgyWjU4UDZ0WVdzN3RndlNUNjVaNA?oc=5\" target=\"_blank\">Amgen at the Milken Future of Health Summit 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-11-24T21:55:04+00:00",
      "source": "Amgen"
    }
  ],
  "product_launches": [
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-01T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - TradingView",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5\" target=\"_blank\">AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "TradingView"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNLXhOdjVpSkxmUXdQRVpHS2tPVUdGcG1EZHJFZDZpNzg5Y3pCT3FTdlVhNFR4MmhicGVQN0luNnNVMkZCOTF5NkR0WWlUOXVtMmtfbzBJWVE4dUlwbjFXX29sREp3enhLVkowNV9QbXd4UGtMTlJjd29PSHNPSUd3TkhJNm55T1AxRTdUazNkd0NHRThWMGtTZU44V3lidnR5UmQyMWZxd0FrcHVPTVlfWTJWQTFMTGRQRDZQcEtaSlc0TklGNzlMam1pRjhDVVVpc0ZRStIB2gFBVV95cUxOV1VkLV9BSGdmbmR6anpGRENtdVctYTJEUUxEdXVCZ25PUV9qbHVNMGoyOFdxSE00TGk3QV9uV3Z2d1hTS0VJaEpmMXNJUzhIZTNjX2JnNHYwN29fQldveUsyWjhQQkR6bDh6dElyZlRDa0dnTDNxN0pNS0xUdVZwdGxaNmZpVVdDNFJ4U1RuZ040dy1wZUJkTXNKbzBIMkZzMlJ2U1c1TEloTmtFUGx3ZERfcGFQQURKUDNWcFdWVzJYQzM5dExHc2ZNQ2czcFU5c1pwOUxoV0NFQQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-11-25",
      "close": 341.1099853515625
    },
    "history": [
      {
        "date": "2025-11-17",
        "close": 339.2900390625
      },
      {
        "date": "2025-11-18",
        "close": 341.55389404296875
      },
      {
        "date": "2025-11-19",
        "close": 339.97515869140625
      },
      {
        "date": "2025-11-20",
        "close": 333.69000244140625
      },
      {
        "date": "2025-11-21",
        "close": 337.5400085449219
      },
      {
        "date": "2025-11-24",
        "close": 334.29998779296875
      },
      {
        "date": "2025-11-25",
        "close": 341.1099853515625
      }
    ],
    "name": "Amgen Inc."
  }
}